This technique has been used in preclinical and early clinical research to deliver anti-inflammatory medicines and monoclonal antibodies targeting cytokines such as IL-1β and TNF-α in neurodegenerative illnesses such as AD [121]. This evidence concerns the gene IL1B and Alzheimer disease.